Keyphrases
Naltrexone
100%
Wound Healing
100%
Fibroblast Proliferation
100%
Opioid Growth Factor Receptor (OGFr)
55%
Opioid Receptors
44%
Fibroblasts
44%
Opioid Antagonist
33%
Cell Growth
22%
3T3 Fibroblasts
22%
Wound Closure
22%
Cutaneous Wound
22%
Receptor-interacting Protein Kinase 1 (RIPK1)
11%
Small Interfering RNA (siRNA)
11%
NIH3T3
11%
Rodents
11%
Specific Receptor
11%
Cell Proliferation
11%
μ-opioid Receptor
11%
Mechanistic Pathway
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Tissue Culture
11%
Diabetic Subjects
11%
Granulation Tissue
11%
Healing Rate
11%
Primary Culture
11%
Primary Cells
11%
Non-diabetic
11%
Selective Antagonist
11%
Specific Ligands
11%
Cell Replication
11%
Full-thickness Wound
11%
δ Opioid Receptor
11%
Kappa Opioid Receptor
11%
Antagonist Treatment
11%
Type 1 Diabetic Rats
11%
Culture Studies
11%
Cutaneous Wound Healing
11%
Subsequent Therapy
11%
DPDPE
11%
Naltrindole
11%
Medicine and Dentistry
Naltrexone
100%
Wound Healing
100%
Fibroblast
100%
Opiate
55%
κ-Opioid Receptor
55%
Growth Factor Receptor
55%
Skin Injury
44%
Opiate Antagonist
33%
Diabetes Mellitus
22%
Receptor
22%
Cell Growth
22%
Wound Closure
22%
In Vitro
11%
Genetic Transfection
11%
Cell Proliferation
11%
Small Interfering RNA
11%
μ-Opioid Receptor
11%
Maturity Onset Diabetes of the Young
11%
Granulation Tissue
11%
Primary Culture
11%
Corneal Epithelium
11%
Receptor Protein
11%
Cell Division
11%
3T3 Cells
11%
Naltrindole
11%
Nalmefene
11%
DAMGO
11%
enkephalin[2,5 Dextro Penicillamine]
11%
Dextro Phenylalanylcysteinyltyrosyl Dextro Tryptophylornithylthreonylpenicillaminylthreoninamide 2,7 Disulfide
11%
Neuroscience
Fibroblast
100%
Naltrexone
100%
Opiate
55%
δ -Opioid Receptor
55%
Growth Factor Receptor
55%
Opioid Antagonist
33%
Eicosanoid Receptor
22%
Diabetes Mellitus
22%
Cell Growth
22%
Receptor Protein
11%
Transfection
11%
In Vitro
11%
μ-Opioid Receptor
11%
Cell Proliferation
11%
Small Interfering RNA
11%
Corneal Epithelium
11%
Cell Division
11%
Primary Culture
11%
DAMGO
11%
Naltrindole
11%
enkephalin[2,5 Dextro Penicillamine]
11%
Nalmefene
11%
Κ-opioid receptor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Wound Healing
100%
Naltrexone
100%
Growth Factor Receptor
55%
Opiate
55%
Opiate Receptor
44%
Skin Injury
44%
Opioid Antagonist
33%
Receptor
22%
Diabetes Mellitus
22%
Receptor Protein
11%
Non Insulin Dependent Diabetes Mellitus
11%
Wound
11%
Granulation Tissue
11%
Primary Culture
11%
Small Interfering RNA
11%
Naltrindole
11%
μ-Opioid Receptor
11%
Nalmefene
11%
enkephalin[2,5 Dextro Penicillamine]
11%
Dextro Phenylalanylcysteinyltyrosyl Dextro Tryptophylornithylthreonylpenicillaminylthreoninamide 2,7 Disulfide
11%
Enkephalin[2 Dextro Alanine 4 Methylphenylalanine 5 Glycine]
11%